This is a Validated Antibody Database (VAD) review about human H-Ras, based on 69 published articles (read how Labome selects the articles), using H-Ras antibody in all methods. It is aimed to help Labome visitors find the most suited H-Ras antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
H-Ras synonym: C-BAS/HAS; C-H-RAS; C-HA-RAS1; CTLO; H-RASIDX; HAMSV; HRAS1; RASH1; p21ras

Knockout validation
Abcam
domestic rabbit monoclonal (Y132)
  • western blot knockout validation; human; 1:1000; fig s2
Abcam H-Ras antibody (Abcam, ab32417) was used in western blot knockout validation on human samples at 1:1000 (fig s2). Cell Death Dis (2016) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (27H5)
  • western blot knockout validation; human; loading ...; fig 4b
  • western blot knockout validation; mouse; fig s2b
Cell Signaling Technology H-Ras antibody (Cell Signaling, 3339T) was used in western blot knockout validation on human samples (fig 4b) and in western blot knockout validation on mouse samples (fig s2b). Cancer Commun (Lond) (2022) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D8H7)
  • western blot knockout validation; mouse; 1:2000; fig 1g
Cell Signaling Technology H-Ras antibody (Cell Signaling, 14429) was used in western blot knockout validation on mouse samples at 1:2000 (fig 1g). Nat Commun (2021) ncbi
Abcam
mouse monoclonal
  • western blot; human; 1:200; loading ...; fig 1a
Abcam H-Ras antibody (Abcam, ab55391) was used in western blot on human samples at 1:200 (fig 1a). elife (2019) ncbi
domestic rabbit monoclonal (EPR3255)
  • western blot; human; 1:1000; loading ...; fig e2b
Abcam H-Ras antibody (Abcam, ab108602) was used in western blot on human samples at 1:1000 (fig e2b). Nature (2019) ncbi
domestic rabbit monoclonal (EPR3255)
  • western blot; roundworm ; loading ...; fig 10e
Abcam H-Ras antibody (Abcam, EPR3255) was used in western blot on roundworm samples (fig 10e). Cancer Cell Int (2019) ncbi
domestic rabbit monoclonal (EPR3255)
  • western blot; human; fig 3b
Abcam H-Ras antibody (Abcam, ab108602) was used in western blot on human samples (fig 3b). Cell (2018) ncbi
domestic rabbit monoclonal (EP1125Y)
  • western blot; human; loading ...; fig 4a
In order to determine the effects of High mobility group box 1 on cytokine secretion from mesenchymal stem cells, Abcam H-Ras antibody (Abcam, ab52939) was used in western blot on human samples (fig 4a). Exp Ther Med (2016) ncbi
domestic rabbit monoclonal (EP1125Y)
  • western blot; human; fig 4c
In order to explore how C-kinase potentiated protein phosphatase-1 inhibitor of 17 kDa drives Ras activity and tumorigenesis, Abcam H-Ras antibody (Abcam, EP1125Y) was used in western blot on human samples (fig 4c). Oncotarget (2016) ncbi
mouse monoclonal
  • western blot; human; loading ...; fig 1
Abcam H-Ras antibody (Abcam, ab55391) was used in western blot on human samples (fig 1). Oncotarget (2016) ncbi
domestic rabbit monoclonal (Y132)
  • western blot knockout validation; human; 1:1000; fig s2
Abcam H-Ras antibody (Abcam, ab32417) was used in western blot knockout validation on human samples at 1:1000 (fig s2). Cell Death Dis (2016) ncbi
domestic rabbit monoclonal (EP1125Y)
  • western blot; human; loading ...; fig 5c
Abcam H-Ras antibody (Abcam, ab52939) was used in western blot on human samples (fig 5c). Oncotarget (2016) ncbi
mouse monoclonal (F132-62)
  • immunocytochemistry; human; loading ...; fig 2c
In order to describe the antitumoral mechanism of vitamin C in KRAS mutant colorectal cancer that is related to the Warburg effect, Abcam H-Ras antibody (Abcam, ab16907) was used in immunocytochemistry on human samples (fig 2c). Oncotarget (2016) ncbi
domestic rabbit monoclonal (Y132)
  • western blot; rat; fig 5
In order to characterize and identify PSD-95 depalmitoylating enzymes, Abcam H-Ras antibody (Abcam, ab32417) was used in western blot on rat samples (fig 5). J Neurosci (2016) ncbi
domestic rabbit monoclonal (EP1125Y)
  • western blot; human; fig s2
Abcam H-Ras antibody (Abcam, ab52939) was used in western blot on human samples (fig s2). Sci Rep (2015) ncbi
mouse monoclonal
  • western blot; human; 1:500; loading ...; fig 3d
Abcam H-Ras antibody (Abcam, ab55391) was used in western blot on human samples at 1:500 (fig 3d). J Pathol (2016) ncbi
mouse monoclonal
  • western blot; mouse; 1:1000; fig 5a
Abcam H-Ras antibody (Abcam, ab55391) was used in western blot on mouse samples at 1:1000 (fig 5a). Mol Cancer Ther (2015) ncbi
mouse monoclonal
  • western blot; human; fig 1
In order to investigate Ras dimerization-dependent signaling, Abcam H-Ras antibody (Abcam, ab55391) was used in western blot on human samples (fig 1). Proc Natl Acad Sci U S A (2015) ncbi
domestic rabbit monoclonal (EPR3255)
  • immunohistochemistry - paraffin section; mouse; 1:50; fig 6
  • immunoprecipitation; human; 1:1000; fig 2
  • immunocytochemistry; human; 1:25; fig 5
  • western blot; human; fig 5
Abcam H-Ras antibody (Abcam, ab108602) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 6), in immunoprecipitation on human samples at 1:1000 (fig 2), in immunocytochemistry on human samples at 1:25 (fig 5) and in western blot on human samples (fig 5). Oncogene (2016) ncbi
mouse monoclonal
  • western blot; human; loading ...; fig 2a
Abcam H-Ras antibody (Abcam, ab55391) was used in western blot on human samples (fig 2a). Mol Carcinog (2016) ncbi
domestic rabbit monoclonal (EP1125Y)
  • western blot; human
In order to study the ERbB signaling network with a view to understanding the basis for context-specific signaling plasticity, Abcam H-Ras antibody (Abcam, ab52939) was used in western blot on human samples . Sci Signal (2013) ncbi
domestic rabbit monoclonal (Y132)
  • western blot; human
Abcam H-Ras antibody (Abcam, ab32417) was used in western blot on human samples . J Biol Chem (2013) ncbi
domestic rabbit monoclonal (EP1125Y)
  • immunoprecipitation; human
  • western blot; human
Abcam H-Ras antibody (Abcam, ab52939) was used in immunoprecipitation on human samples and in western blot on human samples . Biochem J (2013) ncbi
domestic rabbit monoclonal (Y132)
  • western blot; human
Abcam H-Ras antibody (Abcam, ab32417) was used in western blot on human samples . Cell Cycle (2012) ncbi
Santa Cruz Biotechnology
mouse monoclonal (F235)
  • western blot; human; 1:200; loading ...; fig 5c
Santa Cruz Biotechnology H-Ras antibody (Santa Cruz, sc-29) was used in western blot on human samples at 1:200 (fig 5c). J Cell Mol Med (2019) ncbi
mouse monoclonal (F235)
  • western blot; human; loading ...; fig 2c
Santa Cruz Biotechnology H-Ras antibody (SantaCruz, 29) was used in western blot on human samples (fig 2c). Mol Cell Biol (2017) ncbi
mouse monoclonal (F132)
  • western blot; human; loading ...; fig 7a
In order to explore the role of the S100A7 in oral squamous cell carcinoma, Santa Cruz Biotechnology H-Ras antibody (Santa Cruz, S-32) was used in western blot on human samples (fig 7a). Cancer Gene Ther (2016) ncbi
mouse monoclonal (F235)
  • western blot; human; 1:500; fig 5b
Santa Cruz Biotechnology H-Ras antibody (Santa Cruz, sc-29) was used in western blot on human samples at 1:500 (fig 5b). Nat Commun (2016) ncbi
mouse monoclonal (F235)
  • immunohistochemistry - paraffin section; human; 1:500; fig 1
Santa Cruz Biotechnology H-Ras antibody (Santa Cruz, sc-29) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 1). Oncol Lett (2016) ncbi
mouse monoclonal (F235)
  • western blot; human; 1:50; loading ...; fig 2a
In order to describe how a CHK1 inhibitor reduces the growth of radioresistant breast cancer cells, Santa Cruz Biotechnology H-Ras antibody (Santa Cruz, sc-29) was used in western blot on human samples at 1:50 (fig 2a). Oncotarget (2016) ncbi
rat monoclonal (259)
  • immunoprecipitation; human; fig 6
  • western blot; human; fig 6
Santa Cruz Biotechnology H-Ras antibody (Santa Cruz, sc-35l) was used in immunoprecipitation on human samples (fig 6) and in western blot on human samples (fig 6). Oncotarget (2016) ncbi
mouse monoclonal (C-4)
  • western blot; human; fig 1
  • western blot; mouse; fig 1
Santa Cruz Biotechnology H-Ras antibody (Santa Cruz Biotechnology, sc-166691) was used in western blot on human samples (fig 1) and in western blot on mouse samples (fig 1). Cell Commun Signal (2016) ncbi
mouse monoclonal (F235)
  • western blot; mouse; fig 1
Santa Cruz Biotechnology H-Ras antibody (Santa Cruz Biotechnology, sc-29) was used in western blot on mouse samples (fig 1). Oncogene (2016) ncbi
mouse monoclonal (F235)
  • western blot; human; 1:1000
Santa Cruz Biotechnology H-Ras antibody (Santa Cruz, sc-29) was used in western blot on human samples at 1:1000. Nat Commun (2015) ncbi
mouse monoclonal (F235)
  • western blot; human; fig 1
Santa Cruz Biotechnology H-Ras antibody (santa Cruz, sc-29) was used in western blot on human samples (fig 1). PLoS Genet (2015) ncbi
mouse monoclonal (F235)
  • western blot; human; fig 2
Santa Cruz Biotechnology H-Ras antibody (santa Cruz, sc-29) was used in western blot on human samples (fig 2). Oncogene (2015) ncbi
mouse monoclonal (C-4)
  • western blot; human
Santa Cruz Biotechnology H-Ras antibody (Santa, sc-166691) was used in western blot on human samples . Oncogene (2014) ncbi
mouse monoclonal (M90)
  • western blot; rat
Santa Cruz Biotechnology H-Ras antibody (Santa Cruz Biotechnology, M90) was used in western blot on rat samples . Neuropsychopharmacology (2014) ncbi
mouse monoclonal (F235)
  • western blot; human
Santa Cruz Biotechnology H-Ras antibody (Santa Cruz Biotechnology, sc-29) was used in western blot on human samples . Biochem J (2013) ncbi
mouse monoclonal (F235)
  • western blot; human
Santa Cruz Biotechnology H-Ras antibody (Santa Cruz, sc-29) was used in western blot on human samples . J Biol Chem (2013) ncbi
Invitrogen
mouse monoclonal (RAS10)
  • western blot; human; loading ...; fig 4b
In order to discover new regulatory proteins involved in Rap1-dependent T-cell adhesion and migration., Invitrogen H-Ras antibody (Fisher, 10.2) was used in western blot on human samples (fig 4b). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (RAS10)
  • western blot; human; loading ...; fig 1c
In order to determine a critical role of isoprenylcysteine carboxylmethyltransferase in RAS-driven cancers, Invitrogen H-Ras antibody (Pierce, MA1-012) was used in western blot on human samples (fig 1c). Oncogene (2017) ncbi
mouse monoclonal (RAS10)
  • immunoprecipitation; human; 1:50; loading ...; fig 1d
In order to identify Aurora kinase A as a novel Ras binding protein, Invitrogen H-Ras antibody (ThermoScientific, MA1-012X) was used in immunoprecipitation on human samples at 1:50 (fig 1d). Oncotarget (2017) ncbi
mouse monoclonal (RAS10)
  • western blot; human; loading ...; fig 4c
In order to show the Nogo-B receptor promotes accumulation of prenylated Ras at the plasma membrane, Invitrogen H-Ras antibody (Thermo Fischer Scientific, MA1-012) was used in western blot on human samples (fig 4c). Oncogene (2017) ncbi
mouse monoclonal (RAS10)
  • western blot; human; loading ...; fig 4a
In order to propose that increasing calmodulin levels enhance Myc transcriptional and oncogenic activities, Invitrogen H-Ras antibody (Thermo Fisher Scientific, MA1-012) was used in western blot on human samples (fig 4a). Oncotarget (2017) ncbi
rat monoclonal (Y13-259)
  • other; mouse; loading ...; fig 2a
In order to explore how C-kinase potentiated protein phosphatase-1 inhibitor of 17 kDa drives Ras activity and tumorigenesis, Invitrogen H-Ras antibody (ThermoFisher Scientific, Y13-259) was used in other on mouse samples (fig 2a). Oncotarget (2016) ncbi
mouse monoclonal (RAS10)
  • western blot; human; 1:5000; loading ...; fig 4g
In order to demonstrate the bipartite role of Hsp90 in chaperoning CRAF kinase, Invitrogen H-Ras antibody (Thermo Pierce, NA1-012) was used in western blot on human samples at 1:5000 (fig 4g). J Biol Chem (2016) ncbi
mouse monoclonal (RAS10)
  • western blot; mouse; fig 3c
In order to report that ezrin is required for Ras activation, Invitrogen H-Ras antibody (Thermo, RAS10) was used in western blot on mouse samples (fig 3c). Hum Mutat (2015) ncbi
mouse monoclonal (RAS10)
  • western blot; human; fig 1
In order to show that 8.12 is a pharmacological inhibitor of Icmt, Invitrogen H-Ras antibody (Pierce, MA1-012) was used in western blot on human samples (fig 1). Cancer Biol Ther (2014) ncbi
rat monoclonal (Y13-259)
  • immunoprecipitation; mouse; fig 4
In order to determine the role of Ras in solute signaling using a murine inner medullary collecting duct cell line, Invitrogen H-Ras antibody (Zymed, clone Y13-259) was used in immunoprecipitation on mouse samples (fig 4). Am J Physiol Cell Physiol (2000) ncbi
US Biological
domestic rabbit monoclonal (7H56(27H5))
  • western blot; human; loading ...; fig 5a
US Biological H-Ras antibody (US Biological, R1198-01D) was used in western blot on human samples (fig 5a). EBioMedicine (2016) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D8H7)
  • western blot; human; loading ...; fig 1e, 4c
Cell Signaling Technology H-Ras antibody (Cell Signaling, 14429S) was used in western blot on human samples (fig 1e, 4c). Cancer Commun (Lond) (2022) ncbi
domestic rabbit monoclonal (27H5)
  • western blot knockout validation; human; loading ...; fig 4b
  • western blot knockout validation; mouse; fig s2b
Cell Signaling Technology H-Ras antibody (Cell Signaling, 3339T) was used in western blot knockout validation on human samples (fig 4b) and in western blot knockout validation on mouse samples (fig s2b). Cancer Commun (Lond) (2022) ncbi
domestic rabbit monoclonal (D2H12)
  • western blot; human; 1:1000; loading ...; fig 8a
Cell Signaling Technology H-Ras antibody (Cell Signaling Technologies, 14412) was used in western blot on human samples at 1:1000 (fig 8a). Nat Commun (2021) ncbi
domestic rabbit monoclonal (D8H7)
  • western blot; human; 1:1000; loading ...; fig 8a
Cell Signaling Technology H-Ras antibody (Cell Signaling Technologies, 14429) was used in western blot on human samples at 1:1000 (fig 8a). Nat Commun (2021) ncbi
domestic rabbit monoclonal (D8H7)
  • immunohistochemistry; mouse; 1:50; loading ...; fig 4a
Cell Signaling Technology H-Ras antibody (CELL SIGNALING, 14,429) was used in immunohistochemistry on mouse samples at 1:50 (fig 4a). Sci Rep (2021) ncbi
domestic rabbit monoclonal (D8H7)
  • western blot; human; 1:1000; fig 4b
Cell Signaling Technology H-Ras antibody (Cell Signaling, 14429) was used in western blot on human samples at 1:1000 (fig 4b). Front Cell Dev Biol (2021) ncbi
domestic rabbit monoclonal (D8H7)
  • western blot knockout validation; mouse; 1:2000; fig 1g
Cell Signaling Technology H-Ras antibody (Cell Signaling, 14429) was used in western blot knockout validation on mouse samples at 1:2000 (fig 1g). Nat Commun (2021) ncbi
domestic rabbit monoclonal (D2H12)
  • western blot; mouse; 1:500; loading ...; fig s3a
Cell Signaling Technology H-Ras antibody (CST, 14412) was used in western blot on mouse samples at 1:500 (fig s3a). Proc Natl Acad Sci U S A (2021) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 3i
Cell Signaling Technology H-Ras antibody (Cell Signalling, 3965) was used in western blot on mouse samples at 1:1000 (fig 3i). Nat Commun (2020) ncbi
domestic rabbit monoclonal (27H5)
  • western blot; human; 1:2500; fig 1a
Cell Signaling Technology H-Ras antibody (Cell Signaling Technology, 3339) was used in western blot on human samples at 1:2500 (fig 1a). Oncogene (2020) ncbi
domestic rabbit monoclonal (D8H7)
  • western blot; human; loading ...; fig 2d
Cell Signaling Technology H-Ras antibody (Cell Signaling Technology, 14429) was used in western blot on human samples (fig 2d). Autophagy (2020) ncbi
domestic rabbit monoclonal (27H5)
  • western blot; human; loading ...; fig s3b
Cell Signaling Technology H-Ras antibody (Cell Signaling, 3339S) was used in western blot on human samples (fig s3b). Cancer Cell (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 6g
Cell Signaling Technology H-Ras antibody (Cell Signaling, 3965) was used in western blot on human samples at 1:1000 (fig 6g). Int J Oncol (2019) ncbi
domestic rabbit monoclonal (D2H12)
  • western blot; human; loading ...; fig 4b
Cell Signaling Technology H-Ras antibody (Cell Signaling, 14412) was used in western blot on human samples (fig 4b). J Exp Med (2019) ncbi
domestic rabbit monoclonal (D8H7)
  • western blot; mouse; loading ...; fig 2b, 3e
  • western blot; human; loading ...; fig 4f
Cell Signaling Technology H-Ras antibody (Cell Signaling, 14429) was used in western blot on mouse samples (fig 2b, 3e) and in western blot on human samples (fig 4f). Nat Med (2018) ncbi
domestic rabbit monoclonal (27H5)
  • western blot; human; fig 1b
In order to evaluation isoform- and mutation-specific RAS antibodies, Cell Signaling Technology H-Ras antibody (Cell Signaling, 3339) was used in western blot on human samples (fig 1b). Sci Signal (2017) ncbi
domestic rabbit monoclonal (D8H7)
  • western blot; human; loading ...; fig s2b
In order to evaluation isoform- and mutation-specific RAS antibodies, Cell Signaling Technology H-Ras antibody (Cell Signaling, 14429S) was used in western blot on human samples (fig s2b). Sci Signal (2017) ncbi
domestic rabbit monoclonal (D2H12)
  • western blot; human; loading ...; fig s2b
In order to evaluation isoform- and mutation-specific RAS antibodies, Cell Signaling Technology H-Ras antibody (Cell Signaling, 14412S) was used in western blot on human samples (fig s2b). Sci Signal (2017) ncbi
domestic rabbit monoclonal (27H5)
  • western blot; human; fig 3e
In order to find a role for IL-4 in promoting breast cancer aggressiveness, Cell Signaling Technology H-Ras antibody (CST, 27H5) was used in western blot on human samples (fig 3e). Cancer Res (2017) ncbi
domestic rabbit monoclonal (27H5)
  • western blot; human; loading ...; fig 1b
In order to observe that chronic presence of internalized Escherichia coli leads to enhanced oncogenicity in colon cancer cells, Cell Signaling Technology H-Ras antibody (cell signalling, 3339) was used in western blot on human samples (fig 1b). Cell Death Dis (2017) ncbi
domestic rabbit monoclonal (D8H7)
  • western blot; human; fig s6
Cell Signaling Technology H-Ras antibody (Cell Signaling, D8H7) was used in western blot on human samples (fig s6). PLoS ONE (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s1d
Cell Signaling Technology H-Ras antibody (CST, 3965S) was used in western blot on human samples (fig s1d). Nature (2016) ncbi
domestic rabbit monoclonal (D8H7)
  • immunohistochemistry; mouse; 1:50; loading ...; fig 2a
Cell Signaling Technology H-Ras antibody (Cell Signaling, 14429) was used in immunohistochemistry on mouse samples at 1:50 (fig 2a). Cell Rep (2016) ncbi
domestic rabbit monoclonal (27H5)
  • western blot; mouse
In order to elucidate the mechanisms by which KRAS mutations contribute to lung cancer, Cell Signaling Technology H-Ras antibody (Cell Signalling, 3339) was used in western blot on mouse samples . Nature (2016) ncbi
domestic rabbit monoclonal (27H5)
  • western blot; rat; 1:1000; fig 3
Cell Signaling Technology H-Ras antibody (Cell Signaling, 3339) was used in western blot on rat samples at 1:1000 (fig 3). Exp Cell Res (2015) ncbi
domestic rabbit monoclonal (27H5)
  • western blot; human
Cell Signaling Technology H-Ras antibody (Cell Signaling, 3339) was used in western blot on human samples . Mol Cancer Ther (2014) ncbi
domestic rabbit monoclonal (27H5)
  • western blot; human; 1:1000
Cell Signaling Technology H-Ras antibody (Cell Signaling, 3339) was used in western blot on human samples at 1:1000. Cell Death Dis (2013) ncbi
Articles Reviewed
  1. Liu C, Zheng S, Wang Z, Wang S, Wang X, Yang L, et al. KRAS-G12D mutation drives immune suppression and the primary resistance of anti-PD-1/PD-L1 immunotherapy in non-small cell lung cancer. Cancer Commun (Lond). 2022;42:828-847 pubmed publisher
  2. Laliotis G, Chavdoula E, Paraskevopoulou M, Kaba A, La Ferlita A, Singh S, et al. AKT3-mediated IWS1 phosphorylation promotes the proliferation of EGFR-mutant lung adenocarcinomas through cell cycle-regulated U2AF2 RNA splicing. Nat Commun. 2021;12:4624 pubmed publisher
  3. Liot S, El Kholti N, Balas J, Genestier L, Verrier B, Valcourt U, et al. Development of thymic tumor in [LSL:KrasG12D; Pdx1-CRE] mice, an adverse effect associated with accelerated pancreatic carcinogenesis. Sci Rep. 2021;11:15075 pubmed publisher
  4. Urrutia G, de Assunção T, Mathison A, Salmonson A, Kerketta R, Zeighami A, et al. Inactivation of the Euchromatic Histone-Lysine N-Methyltransferase 2 Pathway in Pancreatic Epithelial Cells Antagonizes Cancer Initiation and Pancreatitis-Associated Promotion by Altering Growth and Immune Gene Expression Networks. Front Cell Dev Biol. 2021;9:681153 pubmed publisher
  5. Ischenko I, D Amico S, Rao M, Li J, Hayman M, Powers S, et al. KRAS drives immune evasion in a genetic model of pancreatic cancer. Nat Commun. 2021;12:1482 pubmed publisher
  6. Mrouj K, Andrés Sánchez N, Dubra G, Singh P, Sobecki M, Chahar D, et al. Ki-67 regulates global gene expression and promotes sequential stages of carcinogenesis. Proc Natl Acad Sci U S A. 2021;118: pubmed publisher
  7. Beel S, Kolloch L, Apken L, Jürgens L, Bolle A, Sudhof N, et al. κB-Ras and Ral GTPases regulate acinar to ductal metaplasia during pancreatic adenocarcinoma development and pancreatitis. Nat Commun. 2020;11:3409 pubmed publisher
  8. Wu P, Hong S, Starenki D, Oshima K, Shao H, Gestwicki J, et al. Mortalin/HSPA9 targeting selectively induces KRAS tumor cell death by perturbing mitochondrial membrane permeability. Oncogene. 2020;39:4257-4270 pubmed publisher
  9. Dai E, Han L, Liu J, Xie Y, Kroemer G, Klionsky D, et al. Autophagy-dependent ferroptosis drives tumor-associated macrophage polarization via release and uptake of oncogenic KRAS protein. Autophagy. 2020;:1-15 pubmed publisher
  10. Lee Y, Phelps C, Huang T, Mostofian B, Wu L, Zhang Y, et al. High-throughput single-particle tracking reveals nested membrane domains that dictate KRasG12D diffusion and trafficking. elife. 2019;8: pubmed publisher
  11. Canon J, Rex K, Saiki A, Mohr C, Cooke K, Bagal D, et al. The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity. Nature. 2019;575:217-223 pubmed publisher
  12. Gomes A, Ilter D, Low V, Rosenzweig A, Shen Z, Schild T, et al. Dynamic Incorporation of Histone H3 Variants into Chromatin Is Essential for Acquisition of Aggressive Traits and Metastatic Colonization. Cancer Cell. 2019;36:402-417.e13 pubmed publisher
  13. Ji J, Yuan J, Guo X, Ji R, Quan Q, Ding M, et al. Harmine suppresses hyper-activated Ras-MAPK pathway by selectively targeting oncogenic mutated Ras/Raf in Caenorhabditis elegans. Cancer Cell Int. 2019;19:159 pubmed publisher
  14. Wang L, Shi H, Liu Y, Zhang W, Duan X, Li M, et al. Cystathionine‑γ‑lyase promotes the metastasis of breast cancer via the VEGF signaling pathway. Int J Oncol. 2019;55:473-487 pubmed publisher
  15. Chen H, Poran A, Unni A, Huang S, Elemento O, Snoeck H, et al. Generation of pulmonary neuroendocrine cells and SCLC-like tumors from human embryonic stem cells. J Exp Med. 2019;216:674-687 pubmed publisher
  16. Liu Z, Liu J, Dong X, Hu X, Jiang Y, Li L, et al. Tn antigen promotes human colorectal cancer metastasis via H-Ras mediated epithelial-mesenchymal transition activation. J Cell Mol Med. 2019;23:2083-2092 pubmed publisher
  17. Ruess D, Heynen G, Ciecielski K, Ai J, Berninger A, Kabacaoglu D, et al. Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase. Nat Med. 2018;24:954-960 pubmed publisher
  18. Janes M, Zhang J, Li L, Hansen R, Peters U, Guo X, et al. Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor. Cell. 2018;172:578-589.e17 pubmed publisher
  19. Waters A, Ozkan Dagliyan I, Vaseva A, Fer N, Strathern L, Hobbs G, et al. Evaluation of the selectivity and sensitivity of isoform- and mutation-specific RAS antibodies. Sci Signal. 2017;10: pubmed publisher
  20. Al Khalaf H, Amir M, Al Mohanna F, Tulbah A, Al Sayed A, Aboussekhra A. Obesity and p16INK4A Downregulation Activate Breast Adipocytes and Promote Their Protumorigenicity. Mol Cell Biol. 2017;37: pubmed publisher
  21. Gaggianesi M, Turdo A, Chinnici A, Lipari E, Apuzzo T, Benfante A, et al. IL4 Primes the Dynamics of Breast Cancer Progression via DUSP4 Inhibition. Cancer Res. 2017;77:3268-3279 pubmed publisher
  22. Sahu U, Choudhury A, Parvez S, Biswas S, Kar S. Induction of intestinal stemness and tumorigenicity by aberrant internalization of commensal non-pathogenic E. coli. Cell Death Dis. 2017;8:e2667 pubmed publisher
  23. Strazza M, Azoulay Alfaguter I, Peled M, Smrcka A, Skolnik E, Srivastava S, et al. PLCε1 regulates SDF-1α-induced lymphocyte adhesion and migration to sites of inflammation. Proc Natl Acad Sci U S A. 2017;114:2693-2698 pubmed publisher
  24. Lau H, Tang J, Casey P, Wang M. Isoprenylcysteine carboxylmethyltransferase is critical for malignant transformation and tumor maintenance by all RAS isoforms. Oncogene. 2017;36:3934-3942 pubmed publisher
  25. Umstead M, Xiong J, Qi Q, Du Y, Fu H. Aurora kinase A interacts with H-Ras and potentiates Ras-MAPK signaling. Oncotarget. 2017;8:28359-28372 pubmed publisher
  26. Feng L, Xue D, Chen E, Zhang W, Gao X, Yu J, et al. HMGB1 promotes the secretion of multiple cytokines and potentiates the osteogenic differentiation of mesenchymal stem cells through the Ras/MAPK signaling pathway. Exp Ther Med. 2016;12:3941-3947 pubmed publisher
  27. Zhao B, Hu W, Kumar S, Gonyo P, Rana U, Liu Z, et al. The Nogo-B receptor promotes Ras plasma membrane localization and activation. Oncogene. 2017;36:3406-3416 pubmed publisher
  28. Raffeiner P, Schraffl A, Schwarz T, Röck R, Ledolter K, Hartl M, et al. Calcium-dependent binding of Myc to calmodulin. Oncotarget. 2017;8:3327-3343 pubmed publisher
  29. Riecken L, Zoch A, Wiehl U, Reichert S, Scholl I, Cui Y, et al. CPI-17 drives oncogenic Ras signaling in human melanomas via Ezrin-Radixin-Moesin family proteins. Oncotarget. 2016;7:78242-78254 pubmed publisher
  30. Kenessey I, Kói K, Horváth O, Cserepes M, Molnár D, Izsák V, et al. KRAS-mutation status dependent effect of zoledronic acid in human non-small cell cancer preclinical models. Oncotarget. 2016;7:79503-79514 pubmed publisher
  31. Dey K, Bharti R, Dey G, Pal I, Rajesh Y, Chavan S, et al. S100A7 has an oncogenic role in oral squamous cell carcinoma by activating p38/MAPK and RAB2A signaling pathway. Cancer Gene Ther. 2016;23:382-391 pubmed publisher
  32. Kotsantis P, Silva L, Irmscher S, Jones R, Folkes L, Gromak N, et al. Increased global transcription activity as a mechanism of replication stress in cancer. Nat Commun. 2016;7:13087 pubmed publisher
  33. Mitra S, Ghosh B, Gayen N, Roy J, Mandal A. Bipartite Role of Heat Shock Protein 90 (Hsp90) Keeps CRAF Kinase Poised for Activation. J Biol Chem. 2016;291:24579-24593 pubmed
  34. Gusscott S, Jenkins C, Lam S, Giambra V, Pollak M, Weng A. IGF1R Derived PI3K/AKT Signaling Maintains Growth in a Subset of Human T-Cell Acute Lymphoblastic Leukemias. PLoS ONE. 2016;11:e0161158 pubmed publisher
  35. Anta B, Pérez Rodríguez A, Castro J, García Domínguez C, Ibiza S, Martínez N, et al. PGA1-induced apoptosis involves specific activation of H-Ras and N-Ras in cellular endomembranes. Cell Death Dis. 2016;7:e2311 pubmed publisher
  36. Ho J, Hsu R, Wu C, Liao G, Gao H, Wang T, et al. Reduced miR-550a-3p leads to breast cancer initiation, growth, and metastasis by increasing levels of ERK1 and 2. Oncotarget. 2016;7:53853-53868 pubmed publisher
  37. Friedrich T, Söhn M, Gutting T, Janssen K, Behrens H, Rocken C, et al. Subcellular compartmentalization of docking protein-1 contributes to progression in colorectal cancer. EBioMedicine. 2016;8:159-172 pubmed publisher
  38. Chen Y, LaMarche M, Chan H, Fekkes P, García Fortanet J, Acker M, et al. Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases. Nature. 2016;535:148-52 pubmed
  39. Aguilera O, Muñoz Sagastibelza M, Torrejón B, Borrero Palacios A, del Puerto Nevado L, Martínez Useros J, et al. Vitamin C uncouples the Warburg metabolic switch in KRAS mutant colon cancer. Oncotarget. 2016;7:47954-47965 pubmed publisher
  40. Yokoi N, Fukata Y, Sekiya A, Murakami T, Kobayashi K, Fukata M. Identification of PSD-95 Depalmitoylating Enzymes. J Neurosci. 2016;36:6431-44 pubmed publisher
  41. Rowald K, Mantovan M, Passos J, Buccitelli C, Mardin B, Korbel J, et al. Negative Selection and Chromosome Instability Induced by Mad2 Overexpression Delay Breast Cancer but Facilitate Oncogene-Independent Outgrowth. Cell Rep. 2016;15:2679-91 pubmed publisher
  42. Calaf G, Abarca Quinones J. Ras protein expression as a marker for breast cancer. Oncol Lett. 2016;11:3637-3642 pubmed
  43. Zhang Y, Lai J, Du Z, Gao J, Yang S, Gorityala S, et al. Targeting radioresistant breast cancer cells by single agent CHK1 inhibitor via enhancing replication stress. Oncotarget. 2016;7:34688-702 pubmed publisher
  44. Kerr E, Gaude E, Turrell F, Frezza C, Martins C. Mutant Kras copy number defines metabolic reprogramming and therapeutic susceptibilities. Nature. 2016;531:110-3 pubmed publisher
  45. Carrero Z, Kollareddy M, Chauhan K, Ramakrishnan G, Martinez L. Mutant p53 protects ETS2 from non-canonical COP1/DET1 dependent degradation. Oncotarget. 2016;7:12554-67 pubmed publisher
  46. Hennig A, Markwart R, Wolff K, Schubert K, Cui Y, Prior I, et al. Feedback activation of neurofibromin terminates growth factor-induced Ras activation. Cell Commun Signal. 2016;14:5 pubmed publisher
  47. Beltrán Sastre V, Benisty H, Burnier J, Berger I, Serrano L, Kiel C. Tuneable endogenous mammalian target complementation via multiplexed plasmid-based recombineering. Sci Rep. 2015;5:17432 pubmed publisher
  48. Park Y, Kim S, Kwon T, Kim J, Song I, Shin H, et al. Peroxiredoxin II promotes hepatic tumorigenesis through cooperation with Ras/Forkhead box M1 signaling pathway. Oncogene. 2016;35:3503-13 pubmed publisher
  49. Abu Alainin W, Gana T, Liloglou T, Olayanju A, Barrera L, Ferguson R, et al. UHRF1 regulation of the Keap1-Nrf2 pathway in pancreatic cancer contributes to oncogenesis. J Pathol. 2016;238:423-33 pubmed publisher
  50. Hu S, Lu Y, Orr B, Godek K, Mustachio L, Kawakami M, et al. Specific CP110 Phosphorylation Sites Mediate Anaphase Catastrophe after CDK2 Inhibition: Evidence for Cooperation with USP33 Knockdown. Mol Cancer Ther. 2015;14:2576-85 pubmed publisher
  51. Cho M, Park J, Choi H, Park M, Won H, Park Y, et al. DOT1L cooperates with the c-Myc-p300 complex to epigenetically derepress CDH1 transcription factors in breast cancer progression. Nat Commun. 2015;6:7821 pubmed publisher
  52. Geletu M, Guy S, Greer S, Raptis L. Differential effects of polyoma virus middle tumor antigen mutants upon gap junctional, intercellular communication. Exp Cell Res. 2015;336:223-31 pubmed publisher
  53. Nan X, Tamgüney T, Collisson E, Lin L, Pitt C, Galeas J, et al. Ras-GTP dimers activate the Mitogen-Activated Protein Kinase (MAPK) pathway. Proc Natl Acad Sci U S A. 2015;112:7996-8001 pubmed publisher
  54. Ho J, Nadeem A, Rydström A, Puthia M, Svanborg C. Targeting of nucleotide-binding proteins by HAMLET--a conserved tumor cell death mechanism. Oncogene. 2016;35:897-907 pubmed publisher
  55. Kirschner K, Samarajiwa S, Cairns J, Menon S, Perez Mancera P, Tomimatsu K, et al. Phenotype specific analyses reveal distinct regulatory mechanism for chronically activated p53. PLoS Genet. 2015;11:e1005053 pubmed publisher
  56. Silva G, Aboussekhra A. p16(INK4A) inhibits the pro-metastatic potentials of osteosarcoma cells through targeting the ERK pathway and TGF-β1. Mol Carcinog. 2016;55:525-36 pubmed publisher
  57. Riecken L, Tawamie H, Dornblut C, Buchert R, Ismayel A, Schulz A, et al. Inhibition of RAS activation due to a homozygous ezrin variant in patients with profound intellectual disability. Hum Mutat. 2015;36:270-8 pubmed publisher
  58. Lau H, Ramanujulu P, Guo D, Yang T, Wirawan M, Casey P, et al. An improved isoprenylcysteine carboxylmethyltransferase inhibitor induces cancer cell death and attenuates tumor growth in vivo. Cancer Biol Ther. 2014;15:1280-91 pubmed publisher
  59. Moody S, Schinzel A, Singh S, Izzo F, Strickland M, Luo L, et al. PRKACA mediates resistance to HER2-targeted therapy in breast cancer cells and restores anti-apoptotic signaling. Oncogene. 2015;34:2061-71 pubmed publisher
  60. Kiel C, Verschueren E, Yang J, Serrano L. Integration of protein abundance and structure data reveals competition in the ErbB signaling network. Sci Signal. 2013;6:ra109 pubmed publisher
  61. Wang J, Chen J, Miller D, Li W. Synergistic combination of novel tubulin inhibitor ABI-274 and vemurafenib overcome vemurafenib acquired resistance in BRAFV600E melanoma. Mol Cancer Ther. 2014;13:16-26 pubmed publisher
  62. Zaganjor E, Osborne J, Weil L, Díaz Martínez L, Gonzales J, Singel S, et al. Ras regulates kinesin 13 family members to control cell migration pathways in transformed human bronchial epithelial cells. Oncogene. 2014;33:5457-66 pubmed publisher
  63. Segatto M, Manduca A, Lecis C, Rosso P, Jozwiak A, Swiezewska E, et al. Simvastatin treatment highlights a new role for the isoprenoid/cholesterol biosynthetic pathway in the modulation of emotional reactivity and cognitive performance in rats. Neuropsychopharmacology. 2014;39:841-54 pubmed publisher
  64. Bauckman K, Haller E, Flores I, Nanjundan M. Iron modulates cell survival in a Ras- and MAPK-dependent manner in ovarian cells. Cell Death Dis. 2013;4:e592 pubmed publisher
  65. Haeussler D, Pimentel D, Hou X, Burgoyne J, Cohen R, Bachschmid M. Endomembrane H-Ras controls vascular endothelial growth factor-induced nitric-oxide synthase-mediated endothelial cell migration. J Biol Chem. 2013;288:15380-9 pubmed publisher
  66. BENTLEY C, Jurinka S, Kljavin N, Vartanian S, Ramani S, Gonzalez L, et al. A requirement for wild-type Ras isoforms in mutant KRas-driven signalling and transformation. Biochem J. 2013;452:313-20 pubmed publisher
  67. Vartanian S, BENTLEY C, Brauer M, Li L, Shirasawa S, Sasazuki T, et al. Identification of mutant K-Ras-dependent phenotypes using a panel of isogenic cell lines. J Biol Chem. 2013;288:2403-13 pubmed publisher
  68. Lau R, Niu M, Pratt M. cIAP2 represses IKK?/?-mediated activation of MDM2 to prevent p53 degradation. Cell Cycle. 2012;11:4009-19 pubmed publisher
  69. Tian W, Boss G, Cohen D. Ras signaling in the inner medullary cell response to urea and NaCl. Am J Physiol Cell Physiol. 2000;278:C372-80 pubmed